Adocia Financial Statements From 2010 to 2024

ADOC Stock  EUR 5.81  0.17  2.84%   
Adocia financial statements provide useful quarterly and yearly information to potential Adocia investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Adocia financial statements helps investors assess Adocia's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Adocia's valuation are summarized below:
Adocia does not presently have any fundamental signals for analysis.
Check Adocia financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Adocia's main balance sheet or income statement drivers, such as , as well as many indicators such as . Adocia financial statements analysis is a perfect complement when working with Adocia Valuation or Volatility modules.
  
This module can also supplement various Adocia Technical models . Check out the analysis of Adocia Correlation against competitors.

Adocia Company Current Valuation Analysis

Adocia's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Adocia Current Valuation

    
  33.73 M  
Most of Adocia's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adocia is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Adocia has a Current Valuation of 33.73 M. This is 99.77% lower than that of the Biotechnology sector and 99.27% lower than that of the Health Care industry. The current valuation for all France stocks is 99.8% higher than that of the company.

Adocia Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Adocia's current stock value. Our valuation model uses many indicators to compare Adocia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adocia competition to find correlations between indicators driving Adocia's intrinsic value. More Info.
Adocia is rated fourth in return on equity category among its peers. It is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Adocia by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Adocia's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Adocia Financial Statements

Adocia stakeholders use historical fundamental indicators, such as Adocia's revenue or net income, to determine how well the company is positioned to perform in the future. Although Adocia investors may analyze each financial statement separately, they are all interrelated. For example, changes in Adocia's assets and liabilities are reflected in the revenues and expenses on Adocia's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Adocia. Please read more on our technical analysis and fundamental analysis pages.
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Adocia SA was founded in 2005 and is headquartered in Lyon, France. ADOCIA operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 116 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Adocia Stock

Adocia financial ratios help investors to determine whether Adocia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Adocia with respect to the benefits of owning Adocia security.